Sun Pharma to acquire Canada based Aquinox Pharmaceuticals
The subsidiary of Taro Pharmaceutical will acquire 100 per cent stake in the company.
Mumbai: Sun Pharmaceutical Industries on Wednesday said that a wholly-owned subsidiary of Taro Pharmaceutical Industries Ltd will acquire Aquinox Pharmaceuticals (Canada) Inc for $8.2 million.
Taro Pharmaceutical is a US-based subsidiary of Sun Pharmaceutical.
"One of the wholly owned subsidiaries of our subsidiary company, Taro Pharmaceutical Industries Ltd., has agreed to acquire by way of purchase of all outstanding shares of Aquinox Pharmaceuticals (Canada) Inc.," Sun Pharma said in a regulatory filing.
Aquinox Pharmaceuticals is a corporation organised and existing under the laws of the Province of British Columbia that carries on the business of research and development of pharmaceutical products for purposes of their commercialization, it added.
The subsidiary of Taro Pharmaceutical will acquire 100 per cent stake in the company.
The company said that no approvals are required for the acquisition and it is likely to be completed by July 31.
Sun Pharma shares surged on Wednesday on the back of the announcement. At 10.56 a.m., its shares on the BSE were trading at Rs 491.05, higher by Rs 8.55 or 1.77 per cent from its previous close.
Read also: Sun Pharma aims to protect supply chain, preserve cash amid COVID challenges
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.